Latest From AmnioLife Corp.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2015.
- Gene Therapy, Cell Therapy
- Nanotechnology, Chips, etc.
- Synthesis Technologies, Production Processes
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Wound Healing & Tissue Repair
- North America
- Parent & Subsidiaries
- AmnioLife Corp.
- Senior Management
Chris Broderick, Pres. & CEO
Andrew Hoover, CFO
- Contact Info
Phone: (352) 505-3363
3542 NW 97th Blvd.
Gainesville, FL 32606
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.